Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Stanford University
Stanford University
Takeda
Novartis
Thomas Jefferson University
Celgene
Masonic Cancer Center, University of Minnesota
Virginia Commonwealth University
AbbVie
Takeda
Therapeutic Advances in Childhood Leukemia Consortium
University of Colorado, Denver
Therapeutic Advances in Childhood Leukemia Consortium
Pfizer
Novartis
Celgene
Stanford University
Eli Lilly and Company
Stanford University
AbbVie
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)